发明授权
- 专利标题: Recombinant adenovirus vector having a reduced side effect
- 专利标题(中): 具有降低的副作用的重组腺病毒载体
-
申请号: US10296716申请日: 2001-05-24
-
公开(公告)号: US07445929B2公开(公告)日: 2008-11-04
- 发明人: Michio Nakai , Kazuo Komiya , Masashi Murata , Naoki Tohdoh , Izumu Saito
- 申请人: Michio Nakai , Kazuo Komiya , Masashi Murata , Naoki Tohdoh , Izumu Saito
- 申请人地址: JP Osaka
- 专利权人: Dainippon Sumitomo Pharma Co., Ltd.
- 当前专利权人: Dainippon Sumitomo Pharma Co., Ltd.
- 当前专利权人地址: JP Osaka
- 代理机构: Sughrue Mion, PLLC
- 优先权: JP2000-155603 20000526; JP2000-373850 20001208
- 国际申请: PCT/JP01/04360 WO 20010524
- 国际公布: WO01/90392 WO 20011129
- 主分类号: C12N15/861
- IPC分类号: C12N15/861 ; C12N7/01 ; A61K48/00 ; A61K31/713 ; A01N63/00
摘要:
The present invention provides a novel adenovirus vector for which inflammation during the in vivo administration thereof is alleviated by inhibiting the induction of expression of an adenovirus gene by a foreign promoter inserted into the adenovirus genome, and a method for producing the vector, a cell line for use in the production of the recombinant adenovirus vector, or a gene therapy method using the recombinant adenovirus vector.
公开/授权文献
信息查询
IPC分类: